Genflow Biosciences Plc (GENFF)

$0.01 0.00 (-5.08%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 70,000
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 11%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-...

Industry: Biotechnology
Sector: Healthcare
Address:
6 Heddon Street, London, United Kingdom
Northeast14
Northeast14 Jan. 22 at 8:19 AM
$GENFF one day people will understand what Glenflow are all about
0 · Reply
Northeast14
Northeast14 Jan. 20 at 5:42 PM
$GENFF let’s go Longevity
0 · Reply
Northeast14
Northeast14 Dec. 13 at 8:26 PM
$GENFF let’s go!!
0 · Reply
Northeast14
Northeast14 Dec. 12 at 3:26 PM
$GENFF let’s go Bad Boy!!
0 · Reply
Northeast14
Northeast14 Nov. 11 at 6:56 PM
$GENFF most undervalued stock around
0 · Reply
Northeast14
Northeast14 Nov. 4 at 9:00 PM
$GENFF only the strong will prosper. Patience pays off
0 · Reply
Northeast14
Northeast14 Oct. 22 at 6:38 AM
$GENFF they know it’s going to work! €2,808,175.92 recoverable advance, repayable to the Wallonia region upon commercialisation GF-1002 for use in treating MASH
0 · Reply
Northeast14
Northeast14 Oct. 22 at 6:28 AM
$GENFF Genflow Biosciences Plc (LSE:GENF) (OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce today that it has received official confirmation of €4,026,525 in non-dilutive financial support from the Wallonia region. The funds will support the ongoing development of Genflow's lead gene therapy, GF-1002, for the treatment of Metabolic Associated Steatohepatitis (MASH), a severe and progressive liver disease
0 · Reply
Northeast14
Northeast14 Oct. 14 at 5:44 PM
$LLY Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of the impact of its blockbuster drugs for diabetes and obesity on the use of health-care resources. The Indianapolis-based drugmaker’s investment includes as much as £204 million to establish a Lilly Gateway Labs location in the UK, according to an emailed statement Monday, giving early-stage biotechs access to Lilly’s expertise, lab space and potential financial investment. I WONDER IF THIS WILL BE INTO $GENFF
1 · Reply
Northeast14
Northeast14 Oct. 14 at 3:35 PM
$GENFF
0 · Reply
Latest News on GENFF
No data available.
Northeast14
Northeast14 Jan. 22 at 8:19 AM
$GENFF one day people will understand what Glenflow are all about
0 · Reply
Northeast14
Northeast14 Jan. 20 at 5:42 PM
$GENFF let’s go Longevity
0 · Reply
Northeast14
Northeast14 Dec. 13 at 8:26 PM
$GENFF let’s go!!
0 · Reply
Northeast14
Northeast14 Dec. 12 at 3:26 PM
$GENFF let’s go Bad Boy!!
0 · Reply
Northeast14
Northeast14 Nov. 11 at 6:56 PM
$GENFF most undervalued stock around
0 · Reply
Northeast14
Northeast14 Nov. 4 at 9:00 PM
$GENFF only the strong will prosper. Patience pays off
0 · Reply
Northeast14
Northeast14 Oct. 22 at 6:38 AM
$GENFF they know it’s going to work! €2,808,175.92 recoverable advance, repayable to the Wallonia region upon commercialisation GF-1002 for use in treating MASH
0 · Reply
Northeast14
Northeast14 Oct. 22 at 6:28 AM
$GENFF Genflow Biosciences Plc (LSE:GENF) (OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce today that it has received official confirmation of €4,026,525 in non-dilutive financial support from the Wallonia region. The funds will support the ongoing development of Genflow's lead gene therapy, GF-1002, for the treatment of Metabolic Associated Steatohepatitis (MASH), a severe and progressive liver disease
0 · Reply
Northeast14
Northeast14 Oct. 14 at 5:44 PM
$LLY Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of the impact of its blockbuster drugs for diabetes and obesity on the use of health-care resources. The Indianapolis-based drugmaker’s investment includes as much as £204 million to establish a Lilly Gateway Labs location in the UK, according to an emailed statement Monday, giving early-stage biotechs access to Lilly’s expertise, lab space and potential financial investment. I WONDER IF THIS WILL BE INTO $GENFF
1 · Reply
Northeast14
Northeast14 Oct. 14 at 3:35 PM
$GENFF
0 · Reply
Northeast14
Northeast14 Oct. 14 at 3:15 PM
$ALT money into $GENFF
3 · Reply
Northeast14
Northeast14 Oct. 14 at 2:23 PM
$LBPH money into $GENFF
0 · Reply
Northeast14
Northeast14 Oct. 11 at 7:51 PM
$ALT take a look at $GENFF
1 · Reply
Northeast14
Northeast14 Oct. 11 at 6:30 PM
$LLY have a look at $GENFF under the radar stock. 70/80% of RND funded by grants
0 · Reply
Northeast14
Northeast14 Oct. 11 at 6:26 PM
$GENFF under the radar and cheap! 70/80% of RND funded by grants! $ALT investors should be looking at the cheap $GENF stock
1 · Reply
Northeast14
Northeast14 Oct. 11 at 6:23 PM
$GENFF going into MASH trials next year. Cheap tickets $ALT
0 · Reply
Northeast14
Northeast14 Oct. 11 at 6:11 PM
$CVKD get the bargain $GENFF tickets!!
0 · Reply
Northeast14
Northeast14 Oct. 11 at 6:03 PM
$TWG get into $GENFF under the radar and due a huge move
0 · Reply
Northeast14
Northeast14 Oct. 11 at 5:01 PM
$NUVB take a look at $GENFF under the radar and under valued
0 · Reply
Northeast14
Northeast14 Oct. 11 at 2:14 PM
$TFFP have a look at $GENFF cheap tickets
0 · Reply
Northeast14
Northeast14 Oct. 11 at 2:13 PM
$GENFF
0 · Reply
Northeast14
Northeast14 Oct. 10 at 8:10 PM
@GregoryOnlyGains look into $GENFF an absolute bargain
1 · Reply